Clinical Trial Update: Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating COTI-2 as a monotherapy or in combination for multiple malignancies, sponsored by Critical Outcome Technologies. The cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Head and Neck Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Cancer

Drugs mentioned

• COTI-2 (COTI-2)

Snippet

Sponsor: Critical Outcome Technologies Inc. | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: UNKNOWN